10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2017 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 20, 2018) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents (Note 7) | $ 6,536,200 | 4,582,100 |
| Short-term investments (Note 7) | 1,497,900 | 1,456,500 |
| Accounts receivable, net of allowances of $38.7 (2017) and $40.3 (2016) | 4,546,300 | 4,029,400 |
| Other receivables | 715,900 | 736,900 |
| Inventories (Note 6) | 4,458,300 | 3,561,900 |
| Prepaid expenses and other | 1,447,500 | 734,600 |
| Total current assets | 19,202,100 | 15,101,400 |
| Other Assets | ||
| Investments (Note 7) | 5,678,800 | 5,207,500 |
| Goodwill (Note 8) | 4,370,100 | 3,972,700 |
| Other intangibles, net (Note 8) | 4,029,200 | 4,357,900 |
| Sundry | 2,874,300 | 1,913,800 |
| Total other assets | 16,952,400 | 15,451,900 |
| Property and equipment, net (Note 9) | 8,826,500 | 8,252,600 |
| Total assets | 44,981,000 | 38,805,900 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt (Note 10) | 3,706,600 | 1,937,400 |
| Accounts payable | 1,410,700 | 1,349,300 |
| Employee compensation | 997,900 | 896,900 |
| Sales rebates and discounts | 4,465,100 | 3,914,900 |
| Dividends payable | 590,600 | 548,100 |
| Income taxes payable (Note 13) | 532,900 | 119,100 |
| Other current liabilities | 2,832,100 | 2,220,900 |
| Total current liabilities | 14,535,900 | 10,986,600 |
| Other Liabilities | ||
| Long-term debt (Note 10) | 9,940,500 | 8,367,800 |
| Accrued retirement benefits (Note 14) | 3,513,900 | 2,453,900 |
| Long-term income taxes payable (Note 13) | 3,776,500 | 688,900 |
| Other noncurrent liabilities | 1,546,300 | 2,228,200 |
| Total other liabilities | 18,777,200 | 13,738,800 |
| Eli Lilly and Company Shareholders' Equity (Notes 11 and 12) | ||
| Common stockno par value Authorized shares: 3,200,000 Issued shares: 1,100,672 (2017) and 1,101,586 (2016) | 687,900 | 688,500 |
| Additional paid-in capital | 5,817,800 | 5,640,600 |
| Retained earnings | 13,894,100 | 16,046,300 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss (Note 16) | (5,718,600) | (5,274,000) |
| Cost of common stock in treasury | (75,800) | (80,500) |
| Total Eli Lilly and Company shareholders' equity | 11,592,200 | 14,007,700 |
| Noncontrolling interests | 75,700 | 72,800 |
| Total equity | 11,667,900 | 14,080,500 |
| Total liabilities and equity | 44,981,000 | 38,805,900 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |